FdaApplication
ANDA 220041
Identifiers
- fda_app_no: ANDA220041
Properties
| Property | Value |
|---|---|
| applicant_name | RICONPHARMA LLC |
| application_type | ANDA |
| approval_date | 2026-05-26 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOPIRAMATE | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL |
5 products